Immuno-modulatory Drugs: a Rapid Way to Combat the Tuberculosis
Medicine in Omics（2022）
Abstract
•Mycobacterium tuberculosis (Mtb)is the causal agent of tuberculosis.•Drug-resistant tuberculosis (DR-TB) epidemics pose a potential threat to global health.•Establishing a new drug regimen containing 2–3 new effective drugs requires around 30 years.•Immunomodulatory drugs are an alternative approach to combat the deadly infectious disease tuberculosis.•Repurposing of existing drugs licensed for other diseases has broad treatment alternatives for DR-TB.
MoreTranslated text
Key words
Mycobacterium tuberculosis,Immunomodulatory drugs,Resistance,Antibiotics,Repurposing,China
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined